Cargando…
Effects of Glucocorticoids and Calcitonin on Parathyroid Hormone‐related Protein (PTHrP) Gene Expression and PTHrP Release in Human Cancer Cells Causing Humoral Hypercalcemia
Glucocorticoids are widely used for the treatment of malignancy‐associated hypercalcemia to delay the occurrence of an escape phenomenon inherent in calcitonin therapy. Using parathyroid hormone‐related protein (PTHrP)‐producing squamous carcinoma cells (T3M‐1 and EC‐GI) established in our laborator...
Autores principales: | Kasono, Keizo, Isozaki, Osamu, Sato, Kanji, Sato, Yasuko, Shizume, Kazuo, Ohsumi, Kazuaki, Demura, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918602/ https://www.ncbi.nlm.nih.gov/pubmed/1938595 http://dx.doi.org/10.1111/j.1349-7006.1991.tb01936.x |
Ejemplares similares
-
SAT-153 PTHrP Mediated Hypercalcemia
por: Arguello, Mingxue
Publicado: (2020) -
PTHrP and the PTH/PTHrP receptor are co-expressed in human breast and colon tumours.
por: Carron, J. A., et al.
Publicado: (1997) -
Development of a PTHrP Chemiluminescent Immunoassay to Assess Humoral Hypercalcemia of Malignancy
por: Ashrafzadeh-Kian, Susan Louise, et al.
Publicado: (2021) -
Substernal oxyphil parathyroid adenoma producing PTHrP with hypercalcemia and normal PTH level
por: Gurrado, Angela, et al.
Publicado: (2008) -
PTHrP and breast cancer: more than hypercalcemia and bone metastases
por: Boras-Granic, Kata, et al.
Publicado: (2012)